Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Disposition to Issuer of 17,948 ABUS shares, $89.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Arbutus Biopharma Corp (ABUS) | Disposition to Issuer | 17,948 | $89.7K |
| Sep 24, 2026 | Arbutus Biopharma Corp (ABUS) | Exercise/Conversion | 52,533 | $168.1K |
| Jun 10, 2026 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 78,800 | n/a |
| Mar 20, 2025 | Arbutus Biopharma Corp (ABUS) | Grant/Award | 157,600 | n/a |
| Mar 1, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 135,000 | n/a |
| Nov 22, 2022 | Galera Therapeutics, Inc. (GRTX) | Exercise/Conversion | 10,000 | $10.7K |
| Sep 13, 2022 | Galera Therapeutics, Inc. (GRTX) | Exercise/Conversion | 10,000 | $10.7K |
| Mar 2, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 75,000 | n/a |
| Dec 20, 2021 | Galera Therapeutics, Inc. (GRTX) | Exercise/Conversion | 20,000 | $21.4K |
| Jan 28, 2021 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 75,000 | n/a |